Synfacts, Inhaltsverzeichnis Synfacts 2023; 19(04): 0415DOI: 10.1055/s-0042-1752649 Innovative Drug Discovery and Development Macrocyclization and Scaffold Hopping Improves Selectivity and ADME Properties of HPK1 Inhibitors Rezensent(en): Antonia F. Stepan (Roche) , Ferdinand H. Lutter (Janssen Pharmaceutica) , Ulrich Lücking (FoRx Therapeutics) Artikel empfehlen Abstract Artikel einzeln kaufen Key words Key wordsmacrocycles - kinase inhibition - selectivity - ADME - scaffold hopping Volltext